Medtronic Fourth Quarter Earnings Sneak Peek
Medtronic, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 98 cents per share, a rise of 8.9% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 97 cents. Between one and three months ago, the average estimate moved up. It has been unchanged at 98 cents during the last month. Analysts are projecting profit to rise by 2.4% versus last year to $3.45.
Past Earnings Performance: Last quarter, the company met expectations by reporting net income of 84 cents per share last quarter. In the previous second quarter, the company beat estimates by 2 cents.
Investing Insights: What’s the Future of Microsoft’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a decline of 1.6% in revenue from the year-earlier quarter to $4.23 billion.
Analyst Ratings: Optimism surrounds Medtronic, as 11 analysts rate it as a buy, one rates it as a sell, and 11 rate it as a hold.
A Look Back: In the third quarter, profit rose 1.2% to $935 million (88 cents a share) from $924 million (86 cents a share) the year earlier, meeting analyst expectations. Revenue fell 1.1% to $3.92 billion from $3.96 billion.
On the top line, the company is looking to get back on the right track after last quarter’s drop snapped a string of revenue increases. Revenue rose 2.4% in the fourth quarter of the last fiscal year, 7.3% in the first quarter and 5.9%in the second quarter before dropping in the third quarter.
There has enjoyed solid performance recently heading into this earnings announcement with profit rising by a year-over-year average of 8.8% for the last four quarters.
Stock Price Performance: Between March 20, 2012 and May 16, 2012, the stock price had fallen $1.06 (-2.7%), from $39.28 to $38.22. The stock price saw one of its best stretches over the last year between January 31, 2012 and February 7, 2012, when shares rose for six straight days, increasing 5.4% (+$2.07) over that span. It saw one of its worst periods between April 2, 2012 and April 10, 2012 when shares fell for six straight days, dropping 4.9% (-$1.93) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories: